Leading Blog

AUGUST 14, 2018

Yu examines pharmaceutical companies like Novartis and the soap company P&G to see how they moved across knowledge disciplines to leverage or create new knowledge on how their product was made. Success requires an exact combination of knowledge power and positional power.” Corporate leaders need to absorb career risks….

How To 165

How To Core Competence Pharmaceuticals Creativity 165

Lead Change Blog

JULY 6, 2015

Every project we took on was carefully positioned and aligned with our team’s purpose, values, strategies, and goals. The second example, from a pharmaceutical company, states their purpose is “to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases.” For whom do they do it?

Pharmaceuticals 150

Pharmaceuticals Discount Cooper Tactics 150

Tanveer Naseer

MARCH 10, 2015

The following is a guest piece by Innovation Excellence co-founder Rowan Gibson. What most companies understand now is that the only way to drive profitable growth and wealth creation over the longer term is to innovate. But that’s not the way radical innovators envisage their organizations. This is quite understandable.

How To 100

How To Retail Core Competence Innovation 100

Marshall Goldsmith

FEBRUARY 8, 2018

Co-founder of Rose Park Advisors—Disruptive Innovation Fund. A leading thinker on strategy and breakthrough innovation. Formerly a leader in the automotive, retail, restaurant, media innovation and consulting industries. Leads Tuck’s incredibly innovative coaching program. Leading innovator in HR for over 25 years.

Executive Coaching 70

Executive Coaching CEO Magazine Banking 70

Strategy Driven

NOVEMBER 29, 2016

When it’s time to hire for critical positions within your company, consider the training and certification in military systems offered to service men and women. As we’ve seen, these men and women possess a great deal of learning agility, an indication that they can adapt quickly in new situations.

Agility 50

Agility Pharmaceuticals Self-aware Crisis Management 50

Strategy Driven

JUNE 22, 2018

The more interactions and positive experiences that your customers have with you, the more likely they are to convert from consumer into a brand advocate, and so the message of your brand will spread organically. If you have regular repeat customers, you are on to a winner. Your team is A1.

Audience 50

Audience Niche Marketing How To Marketing Strategy 50

Strategy Driven

DECEMBER 13, 2018

A team of silos does not engender a positive working atmosphere. A few years back, I coached a national pharmaceutical team with distinct geographies. Drawing from his own extensive background and 10 years of research, Douglas innovated the concept of “Team Quotient” (TQ). This atmosphere occasionally becomes toxic.

Team 58

Team Pharmaceuticals Project Learning-by-Doing 58

Harvard Business Review

SEPTEMBER 21, 2018

Corporate directors and executives alike recognize that today’s pace of change continues to accelerate and that firms need to innovate to stay ahead. But are boards doing enough to support innovation, as they should? We found that, overall, innovation does not rank as a top strategic challenge for the majority of boards.

Innovation 10

Innovation Short-term Telecommunications Long-term 10

Harvard Business Review

JUNE 26, 2014

In his 2008 book Patent Failure , Bessen and co-author Michael Meurer argue that after taking the cost of litigation into account, the effect of patenting in all industries except pharmaceuticals and chemicals was to reduce the profitability of innovation rather than to increase it. Innovation Technology'

Innovation 9

Innovation Pharmaceuticals Chemicals Software 9

The Horizons Tracker

AUGUST 19, 2021

It’s a narrative that paints a picture of investors backing perhaps a single startup in an industry, but research from Wharton highlights how VCs increasingly hedge their bets across a number of startups, and what’s more, this practice actually improves the efficiency of innovation in that sector. Supporting innovation.

Efficiency 124

Efficiency Innovation Venture Capitalist Hedge 124

Harvard Business Review

SEPTEMBER 15, 2011

What they found is that America's patent system only provides positive incentives for innovation in two industries: pharmaceuticals and chemicals. Anyone innovating outside of those two industries would be better off if there were no patent system at all.

Innovation 12

Innovation Chemicals Incentives Pharmaceuticals 12

Harvard Business Review

MARCH 14, 2017

For industries that depend on innovation, sustaining it is a constant challenge. These two actions cost almost nothing compared to vast sums often spent — and arguably, often wasted — on efforts to foster innovation. Yet they have already generated tens of millions of dollars in value for Roivant.

Innovation 9

Innovation Company Incentives Industry 9

Strategy Driven

JULY 13, 2011

They don’t tell you how well the business is positioned for future growth and ROIC improvement. It took many years for the company to regain its lost position. Pharmaceutical companies have long needed deep scientific-innovation leadership capabilities but relatively few general managers.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

Lead on Purpose

SEPTEMBER 8, 2009

Over 150 companies, including Durkee, Cremora, San Giorgio, Ronzoni, and McCormick, now use the entire line of Flapper products, and Weatherchem continues to lead the industry in offering the widest, most innovative array of closure products. Filed under: Integrity , Leadership , Purpose , Team Building , Trust Tagged: | Albert J.

Committee 140

Committee Automotive Ethics Productivity 140

Harvard Business Review

JUNE 29, 2015

And a recent working paper out of the Dusseldorf Institute for Competition Economics ( DICE ), a think tank of sorts, focuses on the latter by exploring whether leveraged buyouts (LBOs) make firms more innovative. PE investors don’t typically invest in firms known for innovation. ” There were other limitations. .

LBO 8

LBO Innovation Sample Short-term 8

Coaching Tip

MARCH 15, 2011

Transforming time from an adversary into an ally has helped me develop the positive mindset to be able to dust myself off from my own early business failures and build my company, Weatherchem, into the leader in my industry. . All it takes is the desire to be innovative and creative in tackling a problem. Entrepreneurship.

Pharmaceuticals 84

Pharmaceuticals Creativity Long-term Power 84

Harvard Business Review

FEBRUARY 22, 2011

Editor's note: This post is the first in a three-week series examining innovation in health care, published in partnership with the Advanced Leadership Initiative at Harvard University. Lack of consensus among players in a complex system is one of the biggest barriers to innovation. It's a classic change management problem.

Health Care 15

Health Care Innovation Pharmaceuticals Consensus 15

Harvard Business Review

JUNE 13, 2016

Since 1999, three years after OxyContin was unveiled by Purdue Pharmaceuticals, the rate of drug overdoses in the U.S. Meanwhile, the amount of prescription opioids sold by pharmaceutical companies has quadrupled, despite no proliferation in the amount of reported pain. Commercial.

Incentives 8

Incentives Pharmaceuticals Crisis P&L 8

Harvard Business Review

JUNE 9, 2017

How the most innovative providers are creating value. Yet rarely do conflict-of-interest policies begin with a positive statement endorsing the importance of collaboration for successful translational research, advancing health, and enhancing the productivity of the biomedical enterprise. Sponsored by Optum.

Conflict of Interest 10

Conflict of Interest Pharmaceuticals Policies Industry 10

Harvard Business Review

DECEMBER 27, 2016

But they also found that it is the proportion of managers with a clinical degree that had the largest positive effect; in other words, the separation of clinical and managerial knowledge inside hospitals was associated with worse management. The course culminates in a team-based innovation project presented to hospital leadership.

Management 15

Management 360-Degree Feedback Mayo Training 15

Harvard Business Review

AUGUST 9, 2012

Selling pharmaceuticals in Latin America is not the same as selling them in the United States or Western Europe. Second, in most Latin American countries, pharmaceutical companies are not allowed to advertise directly to consumers. Right off the bat, I can identify four big differences.

Pharmaceuticals 14

Pharmaceuticals Strategy Advertising Price 14

Harvard Business Review

JUNE 20, 2017

For organizations seeking to become more adaptive and innovative, culture change is often the most challenging part of the transformation. Innovation demands new behaviors from leaders and employees that are often antithetical to corporate cultures, which are historically focused on operational excellence and efficiency.

Company 15

Company Agility Innovation Learning-by-Doing 15

Harvard Business Review

OCTOBER 23, 2014

The positions are there for the taking. That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. They are collaborating with (sometimes highly unlikely) partners. They’re also sharing risk. But not for long. The options are tangible.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Harvard Business Review

OCTOBER 7, 2014

The lesson: Frontline people can not only help the top leader validate an innovative new strategy, they can also be a powerful means to convince customers and those in higher levels at your company to buy in. . One day he observed a pharmaceuticals sales rep stop the car and run into a Costco for a few minutes.

CEO 11

CEO Strategy Pharmaceuticals B2B 11

Harvard Business Review

SEPTEMBER 10, 2013

A good idea faces so many obstacles en route to market today that it''s a wonder we have any innovative products at all. Effective means of boosting innovation already exist, but not enough companies are making use of them. I''ll describe both, but first let''s look at what''s wrong with some of the traditional sources of innovation.

Venture Capitalist 8

Venture Capitalist Venture Funding Innovation Incentives 8

Harvard Business Review

JULY 16, 2013

Consider the pharmaceutical industry, the focus of a recent global survey my colleagues and I conducted. I''ve seen this work wonders for a number of companies that want neutral, unvarnished views of their competitive position. A large pharmaceutical firm, for example, was about to make a big bet on a new class of drugs.

Industry 8

Industry Pharmaceuticals Disruptive Innovation Strategic Planning 8

Harvard Business Review

SEPTEMBER 10, 2013

A good idea faces so many obstacles en route to market today that it’s a wonder we have any innovative products at all. Effective means of boosting innovation already exist, but not enough companies are making use of them. You know those baby sea turtles that get eaten by birds and crabs on their way from the nest to the water?

Venture Capitalist 8

Venture Capitalist Venture Funding Innovation Incentives 8

Harvard Business Review

AUGUST 8, 2012

They are expressing overwhelming enthusiasm and pride in taking part in something positive and important. Of course, we sometimes see such passion in the business world, in the wild enthusiasms of R&D professionals in innovative engineering and pharmaceutical companies. So what can the corporate world learn from all this?

Pharmaceuticals 16

Pharmaceuticals Wilde Fashion Engineering 16

Harvard Business Review

MAY 8, 2013

I recently conducted a study of 56 randomly selected companies involved in major change and innovation efforts in the high-tech, retail, pharmaceutical, banking, automotive, insurance, energy, non-profit, and health care industries. Nearly 68% of these large-scale change and innovative efforts failed.

Middle Management 9

Middle Management Management Automotive Pharmaceuticals 9

Harvard Business Review

JANUARY 31, 2013

Second, we see a raft of innovations that will alter how products are designed, manufactured and sold — everything from nanotechnologies to 3D printing. Then, manufacturing's most important role is as a driver of innovation, trade, and productivity. Innovations Are Changing The Way We Design Products. Demand is Shifting.

Globalization 9

Globalization Supply Chain Pharmaceuticals McKinsey 9

Harvard Business Review

MAY 17, 2012

And ad-hoc solutions like positioning babies under bare light bulbs are simply risky. Enter jugaad innovation — a cost-effective approach for creating affordable products and services using limited resources. For us, innovation is a dynamic process that never ends.''. Please share them with us in the comments below.

Incubator 11

Incubator Business Model Entrepreneur Cost 11

Harvard Business Review

JUNE 14, 2017

How the most innovative providers are creating value. But as more data and more data providers flood the market, a competitive position based solely on data becomes impossible to defend. Insight Center. The Leading Edge of Health Care. Sponsored by Optum. Yet too many HCIT providers are still pursuing that data-centric advantage.

Health Care 9

Health Care Levitt Competitive Advantage Pharmaceuticals 9

Harvard Business Review

JULY 14, 2017

A recent survey on easing racial tensions at work by the Center for Talent Innovation found that “The workplace is one of few settings where we commonly interact across racial and ethnic lines.” Companies are perfectly positioned to promote themselves as havens for civility and respect.

Diversity 9

Diversity Politics Survey Incubator 9

Harvard Business Review

FEBRUARY 2, 2015

Steel did in an earlier era of manufacturing, Aquion and innovative firms like it are spearheading economic and employment growth across the country. Indeed, in a world where globalization and rapid technological changes are the norm, manufacturing, high-tech development, and innovation clearly require a different level of support.

Industry 8

Industry McKinsey Engineering Innovation 8

Harvard Business Review

OCTOBER 26, 2011

When biotechnology startups like Genentech began to acquire other startups to retain their edge, pharmaceutical incumbents were forced to enter the acquisition melee to remain competitive. By using these strategies, clean energy startups can better position themselves for acquisitions and promising exits.

Energy 11

Energy Finance IPO Biotechnology 11

Harvard Business Review

FEBRUARY 4, 2013

Our research with members of the global C-suite, and with leading sustainability and innovation experts, has identified seven vectors of breakthrough change. Perhaps surprisingly, two leading examples come from pharmaceutical companies. Governments, investors and the social innovation sector should support them to the hilt.

EPS 8

EPS Innovation CEO Pharmaceuticals 8

Harvard Business Review

DECEMBER 23, 2016

Heat degrades the substrate of innovation, while light catalyzes it.” Lilly’s research shows these same effects can happen between members of alliance innovation teams. Conflict sharpens the senses; it invites full engagement in solving important problems. Focus your conflict-management resources where it matters most.

Productivity 8

Productivity Products Survey Strategic Fit 8